Patients With Moderate to Severe Ulcerative Colitis: Study of Vedolizumab
6/2/2009

Alabama, California, Colorado, Connecticut, Florida, Georgia, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington; Puerto Rico. clinicaltrials.gov

Related Summaries